alexa Vinca Alkaloids Induced Peripheral Neuropathy: Case Series
ISSN: 1948-5956

Journal of Cancer Science & Therapy
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

14th World Cancer & Anti-Cancer Therapy Convention
November 21-23, 2016 Dubai, UAE

Shahbaz Ahmad Khan, Abdul Hameed and Sahar Malik
Shaukat Khanum Cancer Hospital, Pakistan
ScientificTracks Abstracts: J Cancer Sci Ther
DOI: 10.4172/1948-5956.C1.093
Abstract
Statement of Problem: Peripheral neuropathy is one of the commonest side effects of vinca alkaloids due to decreased level of serum folate and vitamin B 12, underlying hepatic impairment and concurrent drugs which decrease vinca alkaloids hepatic metabolism. Although lot of research is done in western countries but incident is less studied in eastern population. The purpose of this study is to find out the etiology of vinca alkaloids induced peripheral neuropathy in local population. Research in our study was done on seven patients; case series of seven patients who suffered from vinca alkaloids induced periphweral neuropathy. Findings: Only one out of seven patients had low serum folate acid level while rest of the parameters were normal. Baseline renal hepatic functions were normal in the listed patients; most common symptoms were numbness and tingling of hands and feet. Weakness of arms or legs was also observed in some patients. Most patients developed these symptoms after 3-4 cycles of vinca alkaloids, showing a dose dependent pattern. Conclusions & Significance: The study findings are slightly contrary to data available which showed vinca alkaloids induced peripheral neuropathy associated with low serum folic acid level or deranged hepatic functions. More than half of the patients developed peripheral neuropathy after receiving at least 3 doses of vinca alkaloids. This seems in relation with the cumulative dose rather than after a single dose incident; almost all patients had advanced stage disease. Two patients later diagnosed to have CNS disease that may be contributing to symptoms of patients as well. So it is important to rule out CNS disease in non-Hodgkin lymphoma patients, in particular if PN symptoms are getting worse even after stopping the culprit agent. So it became very evident from the study that patients suffering PN had very different risk factors from those described in literature. Recommendations: As most of the literature and research work is done in western countries, the result from this study strongly emphasizes the need of research in eastern population and so that we may be able to find a comprehensive etiology to modify drug therapy accordingly.
Biography

Shahbaz Ahmad Khan is Senior Clinical Oncology Pharmacist in Shaukat Khanum Cancer Hospital, Pakistan with 7 years of experience in Oncology. His area of interest is optimization of cancer drug therapy for cancer patients. He did Master of Philosophy in Pharmaceutical Sciences after PharmD. He also holds MBA degree to improve his management skills. He has participated in several phase III drug trials in his organization with multinational companies. Currently, he is working closely with oncologist and research team in SKMCH & RC to identify the underlying side effects and toxicities caused by cytotoxic drugs in cancer patients. His research work ifosfamide induced peripheral neuropathy is also in process for publication. His keen interest is to address the etiology and to suggest the appropriate treatment for anticancer drug therapy. He is also involved extensively in education and training of cancer drug therapy nationwide to raise the level of oncology services in country.

Email: [email protected]

image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

social_polit[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords